Display options
Cite
Györfi AH, Schett G, Distler JHW. Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny . Ann Rheum Dis. 2020;doi: 10.1136/annrheumdis-2020-218983.
Györfi, A. H., Schett, G., & Distler, J. H. W. (2020). Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny . Annals of the rheumatic diseases, . https://doi.org/10.1136/annrheumdis-2020-218983
Györfi, Andrea Hermina, et al. "Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny ." Annals of the rheumatic diseases vol. (2020). doi: https://doi.org/10.1136/annrheumdis-2020-218983
Györfi AH, Schett G, Distler JHW. Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny . Ann Rheum Dis. 2020 Oct 01; doi: 10.1136/annrheumdis-2020-218983. Epub 2020 Oct 01. PMID: 33004332.
Copy Download .nbib Format: NLM
Share it on

Ann Rheum Dis. 2020 Oct 01; doi: 10.1136/annrheumdis-2020-218983. Epub 2020 Oct 01.

Response to: 'Correspondence on 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis'' by Jeny .

Annals of the rheumatic diseases

Andrea Hermina Györfi, Georg Schett, Jörg H W Distler

Affiliations

  1. Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany.
  2. Department of Internal Medicine 3 - Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, Erlangen, Germany [email protected].

PMID: 33004332 DOI: 10.1136/annrheumdis-2020-218983

[No abstract available.]

Keywords: biological therapy; glucocorticoids; sarcoidosis

Conflict of interest statement

Competing interests: JHWD is involved in the development of new targeted therapies for fibrotic diseases such as systemic sclerosis. JHWD has consultancy relationships with Actelion, Active Biotech, A

Publication Types